Evidence map›Paper›PMID 22104028›Full record

ArticleMolecular & cellular proteomics : MCP2012

Effect of single amino acid substitution on oxidative modifications of the Parkinson's disease-related protein, DJ-1.

Ashraf G Madian, Jagadish Hindupur, John D Hulleman, Naomi Diaz-Maldonado, Vartika R Mishra, Emmanuel Guigard, Cyril M Kay, Jean-Christophe Rochet, Fred E Regnier

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Protein Oxidative Modifications: Beneficial Roles in Disease and Health.Journal of biochemical and pharmacological research · 2013
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ashraf G MadianDepartment of Chemistry, Purdue University, West Lafayette, Indiana 47907, USA.
Jagadish Hindupur
John D Hulleman
Naomi Diaz-Maldonado
Vartika R Mishra
Emmanuel Guigard
Cyril M Kay
Jean-Christophe Rochet
Fred E Regnier
Purdue University West Lafayette · US

Funding

APT: the Analytical Proteomics TeamU24CA126480 · NCI · PURDUE UNIVERSITY · PI REGNIER, FRED E · 2006 to 2010
$6.4M
MITOCHONDRIAL PROTEOMICS OF AGINGR01AG025362 · NIA · PURDUE UNIVERSITY WEST LAFAYETTE · PI REGNIER, FRED E · 2004 to 2008
$1.2M
Mechanisms of DJ-1 Protection against methamphetamine neurotoxicity.R03DA027111 · NIDA · PURDUE UNIVERSITY · PI ROCHET, JEAN-CHRISTOPHE · 2011 to 2012
$144k
NCI NIH HHS 1U24CA126480-0NCI NIH HHS U24 CA126480NIA NIH HHS 5R01AG025362-02NIA NIH HHS R01 AG025362NIDA NIH HHS 1R03DA027111-01NIDA NIH HHS R03 DA027111
6 · The paper itself

Abstract

Mutations in the gene encoding DJ-1 have been identified in patients with familial Parkinson's disease (PD) and are thought to inactivate a neuroprotective function. Oxidation of the sulfhydryl group to a sulfinic acid on cysteine residue C106 of DJ-1 yields the "2O " form, a variant of the protein with enhanced neuroprotective function. We hypothesized that some familial mutations disrupt DJ-1 activity by interfering with conversion of the protein to the 2O form. To address this hypothesis, we developed a novel quantitative mass spectrometry approach to measure relative changes in oxidation at specific sites in mutant DJ-1 as compared with the wild-type protein. Treatment of recombinant wild-type DJ-1 with a 10-fold molar excess of H(2)O(2) resulted in a robust oxidation of C106 to the sulfinic acid, whereas this modification was not detected in a sample of the familial PD mutant M26I exposed to identical conditions. Methionine oxidized isoforms of wild-type DJ-1 were depleted, presumably as a result of misfolding and aggregation, under conditions that normally promote conversion of the protein to the 2O form. These data suggest that the M26I familial substitution and methionine oxidation characteristic of sporadic PD may disrupt DJ-1 function by disfavoring a site-specific modification required for optimal neuroprotective activity. Our findings indicate that a single amino acid substitution can markedly alter a protein's ability to undergo oxidative modification, and they imply that stimulating the conversion of DJ-1 to the 2O form may be therapeutically beneficial in familial or sporadic PD.

Indexed as

Amino Acid SubstitutionCysteineHumansHydrogen PeroxideIntracellular Signaling Peptides and ProteinsMethionineMutationOncogene ProteinsOxidantsOxidation-ReductionPeptide FragmentsProtein Deglycase DJ-1Spectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSulfinic AcidsCysteineHydrogen PeroxideIntracellular Signaling Peptides and ProteinsMethionineOncogene ProteinsOxidantsPARK7 protein, humanPeptide FragmentsProtein Deglycase DJ-1Sulfinic Acids

Identifiers

PMID22104028
PMCPMC3277756
OpenAlexW2091090367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.